Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2013

01-05-2013 | Original Paper

Depression, Substance Abuse and Other Contextual Predictors of Adherence to Antiretroviral Therapy (ART) Among Haitians

Authors: Robert Malow, Jessy G. Dévieux, Judith A. Stein, Rhonda Rosenberg, Michele Jean-Gilles, Jennifer Attonito, Serena P. Koenig, Giuseppe Raviola, Patrice Sévère, Jean W. Pape

Published in: AIDS and Behavior | Issue 4/2013

Login to get access

Abstract

Haiti has the highest number of individuals living with HIV in the Caribbean. Due to Haiti’s resource-poor environment and inadequate mental health and substance abuse services, adherence to antiretroviral therapy (ART) may be especially difficult. This study examined associations among demographics, maladaptive coping, partner conflict, alcohol problems, depression, and negative attitudes about medications and their impact on adherence among 194 HIV-positive Haitians. In a mediated directional structural equation model, depression and negative attitudes about ART directly predicted poorer adherence. Greater partner conflict, maladaptive coping and alcohol problems predicted more depression. Maladaptive coping predicted a negative attitude about ART. Alcohol problems predicted partner conflict and maladaptive coping. Significant indirect effects on adherence mediated through both depression and negative attitudes about ART include negative effects of female gender, alcohol problems and maladaptive coping. Results highlight the importance of integrated care for depression, alcohol use and other psychosocial problems to increase ART adherence.
Footnotes
1
Wherever a coefficient alpha was provided without citing another source, the statistic was calculated for this study sample. These coefficients reflected the Creole versions of instruments.
 
Literature
1.
Barreto S, Miranda J, Figueroa J, et al. Epidemiology in Latin America and the Caribbean: current situation and challenges. Int J Epidemiol. 2012;41(2):557–71.PubMedCrossRef
2.
Malow R, Rosenberg R, Lichtenstein B, Dévieux J. The impact of disaster on HIV in Haiti and priority areas related to the Haitian crisis. J Assoc Nurses AIDS Care. 2010;21(3):283–8.PubMedCrossRef
3.
Dowell S, Tappero J, Frieden T. Public health in Haiti—challenges and progress. N Engl J Med. 2011;364(4):300–1.PubMedCrossRef
4.
Hotez P, Bottazzi M, Franco-Paredes C, Ault S, Periago M. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis. 2008;2(9):e300.PubMedCrossRef
5.
6.
7.
United Nations Development Programme. Human Development Report. United Nations; 2011.
8.
9.
Deschamps M, Pape J, Hafner A, Johnson W. Heterosexual Transmission of HIV in Haiti. Ann Intern Med. 1996;125:324–30.PubMedCrossRef
10.
Malow R, Rosenberg R, Dévieux J. Cognitive-behavioral stress management interventions for ethnic-minority HIV-positive alcohol/drug abusers in resource limited and culturally diverse communities. Am J Infect Dis. 2009;5(1):48–59.CrossRef
11.
12.
Blashill A, Perry N, Safren S. Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep. 2011;8(4):215–22.PubMedCrossRef
13.
Nachega J, Morroni C, Zuniga J, et al. HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS Treatment for Life international survey. J Int Assoc Physicians AIDS Care. 2012;11(2):128–33.CrossRef
14.
Nakimuli-Mpungu E, Bass J, Alexandre P, et al. Depression, alcohol use and adherence to antiretroviral therapy in Sub-Saharan Africa: a systematic review. AIDS Behav. 2011;16(8):2101–18.CrossRef
15.
Pence B. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother. 2009;63(4):636–40.PubMedCrossRef
16.
Kahana S, Rohan J, Allison S, Frazier T, Drotar D. A meta-analysis of adherence to antiretroviral therapy and virologic responses in HIV-infected children, adolescents, and young adults. AIDS Behav. 2013;17(1):41–60.
17.
Smith-Fawzi M, Eustache E, Oswald C, et al. Psychosocial functioning among HIV-affected youth and their caregivers in Haiti: implications for family-focused service provision in high HIV burden settings. AIDS Patient Care STDs. 2010;24(3):147–58.PubMedCrossRef
18.
Parker R, Easton D, Charles H. Structural barriers and facilitators in HIV prevention: a review of international research. AIDS. 2000;14(S1):S22–S32.
19.
Garvie P, Flynn P, Belzer M, et al. Psychological factors, beliefs about medication, and adherence of youth with Human Immunodeficiency Virus in a multisite directly observed therapy pilot study. J Adolesc Health. 2011;48:637–40.PubMedCrossRef
20.
Dévieux J, Malow R, Jean-Gilles M, et al. Reducing health disparities through culturally sensitive treatment for HIV+ adults in Haiti. ABNF J. 2004;15(6):109–15.PubMed
21.
Namuddu B, Kalyango J, Karamagi C, et al. Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health. 2011;11:855.PubMedCrossRef
22.
Dévieux J, Deschamps M, Malow R, et al. Barriers to care among HIV + Haitians: an examination of sociocultural factors. In: Pope C, White R, Malow R, editors. HIV/AIDS: global frontiers in prevention/intervention. New York: Routledge; 2009. p. 238–45.
23.
24.
Bianco J, Heckman T, Sutton M, Watakakosol R, Lovejoy T. Predicting adherence to antiretroviral therapy in HIV-infected older adults: the moderating role of gender. AIDS Behav. 2011;15(7):1437–46.PubMedCrossRef
25.
Cruess D, Kalichman S, Amaral C, Swetzes C, Cherry C, Kalichman M. Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS. Ann Behav Med. 2012;43(2):189–97.PubMedCrossRef
26.
Grenard J, Munjas B, Adams J, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175–82.PubMedCrossRef
27.
Johnson M, Dilworth S, Taylor J, Neilands T. Improving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV. Ann Behav Med. 2011;41(1):83–91.PubMedCrossRef
28.
Nel A, Kagee A. Common mental health problems and antiretroviral therapy adherence. AIDS Care. 2011;23(11):1360–5.PubMedCrossRef
29.
Rao D, Feldman B, Fredericksen R, et al. A structural equation model of HIV-related stigma, depressive symptoms, and medication adherence. AIDS Behav. 2012;16(3):711–6.PubMedCrossRef
30.
Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression—a systematic review of interventions. Psychol Health Med. 2011;16(5):493–527.PubMedCrossRef
31.
Soller M, Kharrazi N, Prentiss D, et al. Utilization of psychiatric services among low-income HIV-infected patients with psychiatric comorbidity. AIDS Care. 2011;23(11):1351–9.PubMedCrossRef
32.
Talukdar A, Tallukdar P, Ghosal M, Bal R, Ghosh P, Goswami D. Evaluation of depression and coping skill among HIV-positive people in Kolkata, India. J Int Assoc Physicians AIDS Care. 2012;11(2):115–20.CrossRef
33.
Wagner G, Goggin K, Remien R, et al. A closer look at depression and its relationship to HIV antiretroviral adherence. Ann Behav Med. 2011;42(3):352–60.PubMedCrossRef
34.
Bottonari K, Tripathi S, Fortney J, et al. Correlates of antiretroviral and antidepressant adherence among depressed HIV-infected patients. AIDS Patient Care STDs. 2012;26:265–73.PubMedCrossRef
35.
Baum M, Rafie C, Lai S, Sales S, Page J, Campa A. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 2010;26(5):511–8.PubMedCrossRef
36.
Pan American Health Organization. Antiretroviral treatment in the spotlight: a public health analysis in Latin America and the Caribbean. Alonso González M, ed. Washington, DC: PAHO; 2012.
37.
Gonzalez J, Batchelder A, Psaros C, Safren S. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr. 2011;58(2):181–7.PubMed
38.
O’Neil C, Palmer A, Coulter S, et al. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada. J Int Assoc Physicians AIDS Care. 2012;11(2):134–41.CrossRef
39.
Dévieux JG, Malow RM, Rosenberg R, et al. Cultural Adaptation in Translational Research: Field Experiences. J Urban Health. 2005; 82(2):iii82-iii91.
40.
Carver C, Scheier M, Weintraub J. Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol. 1989;56:267–83.PubMedCrossRef
41.
Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993;88:791–804.PubMedCrossRef
42.
Maisto S, Conigliaro J, McNeil M, Kraemer K, Kelley M. An empirical investigation of the factor structure of the AUDIT. Psych Assess. 2000;12(3):346–53.CrossRef
43.
Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
44.
Yuan K, Bentler P, Kano Y. On averaging variables in a confirmatory factor analysis model. Behaviormetrika. 1997;24:71–83.CrossRef
45.
Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.PubMedCrossRef
46.
Bentler P. EQS 6 structural equations program manual. Encino, CA: Multivariate Software, Inc.; 2006.
47.
Hu L. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6:1–55.CrossRef
48.
Chou C, Bentler P. Model modification in covariance structure modeling: a comparison among likelihood ratio, Lagrange Multiplier, and Wald tests. Multivar Behav Res. 1990;25:115–36.CrossRef
49.
MacCallum R. Specification searches in covariance structure modeling. Psychol Bull. 1986;100:107–20.CrossRef
50.
Sumari-deBoer I, Sprangers M, Prins J, Nieuwker P. HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS Behav. 2012;16(6):1681–9.CrossRef
51.
Kong M, Nahata M, Lacombe V, Seiber E, Balkrishnan R. Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection. J Gen Intern Med. 2012;27(9):1159–64.PubMedCrossRef
52.
Patel V, Chowdhary N, Rahman A, Verdeli H. Improving access to psychological treatments: lessons from developing countries. Behav Res Therapy. 2011;49(9):523–8.CrossRef
53.
Coleman SM, Gandhi R, Safren S, Freudenreich O. Impact of integrated and measurement-based depression care: clinical experience in an HIV clinic. Psychosomatics. 2012;53(1):51–7.PubMedCrossRef
54.
Curran G, Pyne J, Fortney J, et al. Development and implementation of collaborative care for depression in HIV clinics. AIDS Care. 2011;23(12):1626–36.PubMedCrossRef
55.
Simoni J, Safren S, Manhart L, et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav. 2011;15(2):376–88.PubMedCrossRef
56.
Cohen M, McCauley M, Gamble T. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7(2):99–105.PubMedCrossRef
57.
Forsyth A, Valdiserri R. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052. Curr Opin HIV AIDS. 2012;7(2):111–6.PubMedCrossRef
58.
Nachega J, Mills E, Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010;5(1):70–7.PubMedCrossRef
59.
Kang S, Deren S, Colon H. Differential gender effects of depression on use of HIV medications among HIV-positive Puerto Rican drug users. AIDS Care. 2011;23(11):1467–71.PubMedCrossRef
60.
Gordillo V, Fekete E, Platteau T, et al. Emotional support and gender in people living with HIV: effects on psychological well-being. J Behav Med. 2009;32(6):523–31.PubMedCrossRef
61.
Connell RW. Gender and power: society, the person and sexual politics. Stanford, CA: Stanford University Press; 1988.
62.
Wingood GM, DiClemente RJ. Application of the theory of gender and power to examine HIV-related exposures, risk factors, and effective interventions for women. Health Educ Behav. 2000;27:539–65.PubMedCrossRef
63.
Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281–8.PubMedCrossRef
64.
Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36(5):1100–2.PubMedCrossRef
65.
Milan S, Ickovics J, Vlahov D, et al. Interpersonal predictors of depression trajectories in women with HIV. J Consult Clin Psychol. 2005;73(4):678–88.PubMedCrossRef
66.
Campbell J, Baty M, Ghandour R, Stockman J, Francisco L, Wagman J. The intersection of intimate partner violence against women and HIV/AIDS: a review. Int J Inj Contr Saf Promot. 2008;15(4):221–31.PubMedCrossRef
67.
Harling G, Msisha W, Subramanian S. No association between HIV and intimate partner violence among women in 10 developing countries. PLoS ONE. 2010;5(12):8.CrossRef
68.
Breiding M, Black M, Ryan G. Chronic disease and health risk behaviors associated with intimate partner violence-18 U.S. states/territories, 2005. Ann Epidemiol. 2008;18(7):538–44.PubMedCrossRef
69.
Schafer K, Brant J, Gupta S, et al. Intimate partner violence: a predictor of worse HIV outcomes and engagement in care. AIDS Patient Care STDs. 2012;26(6):356–65.PubMedCrossRef
70.
Kennedy A, Adams A, Bybee D, Campbell R, Kubiak S, Sullivan C. A model of sexually and physically victimized women’s process of attaining effective formal help over time: the role of social location, context, and intervention. Am J Community Psychol. 2012;50(1–2):217–28.PubMedCrossRef
71.
Ribeiro W, Andreoli S, Ferri C, Prince M, Mari J. Exposure to violence and mental health problems in low and middle-income countries: a literature review. Revista brasileira de psiquiatria. 2009; 31(S2):S49–S57.
72.
Gage A. Women’s experience of intimate partner violence in Haiti (1982). Soc Sci Med. 2005;61(2):343–64.PubMedCrossRef
73.
Gage A, Hutchinson P. Power, control, and intimate partner sexual violence in Haiti. Arch Sex Behav. 2006;35(1):11–24.PubMedCrossRef
74.
Gómez A, Speizer I, Beauvais H. Sexual violence and reproductive health among youth in Port-au-Prince, Haiti. J Adolesc Health. 2009;44(5):508–10.PubMedCrossRef
75.
Klinkenberg W, Calsyn R, Morse G, McCudden S, Richmond T, Burger G. Consistency of recall of sexual and drug-using behaviors for homeless persons with dual diagnosis. AIDS Behav. 2002;6(4):295–307.CrossRef
76.
Koenig S, Ivers LC, Pace S, et al. Successes and challenges of HIV treatment programs in Haiti: aftermath of the earthquake. HIV Therapy. 2010;4:145–60.PubMedCrossRef
77.
WHO; UNFPA; UNAIDS; IPPF. Linking sexual and reproductive health and HIV/AIDS, gateways to integration: a case study from Haiti. Geneva: WHO Press; 2008.
78.
Bass JK, Bornemann TH, Burkey M, et al. A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come. PLoS Med. 2012;9(1):e1001159.
79.
Raviola G, Eustache E, Oswald C, Belkin GS. Mental health response in Haiti in the aftermath of the 2010 earthquake: a case study for building long-term solutions. Harv Rev Psychiatry. 2012;20(1):68–77.
80.
Belkin GS, Unützer J, Kessler RC, et al. Scaling up for the “Bottom Billion”: “5 × 5” implementation of community mental health care in low-income regions psychiatric services. Psychiatr Serv. 2011;62(12):1450–94.CrossRef
Metadata
Title
Depression, Substance Abuse and Other Contextual Predictors of Adherence to Antiretroviral Therapy (ART) Among Haitians
Authors
Robert Malow
Jessy G. Dévieux
Judith A. Stein
Rhonda Rosenberg
Michele Jean-Gilles
Jennifer Attonito
Serena P. Koenig
Giuseppe Raviola
Patrice Sévère
Jean W. Pape
Publication date
01-05-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0400-1

Other articles of this Issue 4/2013

AIDS and Behavior 4/2013 Go to the issue

Original Paper

High Prevalence of Substance Use Among Men Who have Sex with Men in Buenos Aires, Argentina: Implications for HIV Risk Behavior

Original Paper

Understanding of Norms Regarding Sexual Practices Among Gay Men: Literature Review

Original Paper

Factors Associated with Men in HIV-Negative Gay Couples Who Practiced UAI Within and Outside of Their Relationship

Original Paper

“It’s Hard to Know What is a Risky or not a Risky Decision”: Gay Men’s Beliefs About Risk During Sex

Original Paper

Perceived Discrimination and Physical Health Among HIV-Positive Black and Latino Men Who Have Sex with Men

Original Paper

Prevalence and Predictors of Conscious Risk Behavior Among San Franciscan Men who have Sex with Men
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits